Virtual reality could help spot thinking problems in MS patients
NCT ID NCT03768648
First seen May 22, 2026 · Last updated Jun 23, 2026 · Updated 5 times
Summary
This completed study looked at 75 people with relapsing-remitting multiple sclerosis (RRMS) who were taking the medication Aubagio. The goal was to see if virtual reality tests and real-world tasks could better detect cognitive (thinking) problems in everyday life compared to standard tests. Researchers also used advanced MRI scans to examine brain structure and connections. The study did not test a new treatment but aimed to improve how cognitive issues are identified and tracked in MS.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Bordeaux - Service de neurologie
Bordeaux, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Aubagio (teriflunomide)
What this could lead to
If successful, this could lead to better ways to detect and track cognitive problems in daily life for people with MS, using virtual reality tests.
What could go wrong
This is an observational study with no new treatment being tested. The results may not change current care, and the virtual reality tests may not prove more useful than standard assessments.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.